• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • Mitchell S Cairo, Mary Gerrard, +8 authors Catherine Patte
  • Medicine
  • Blood
  • 2007 (First Publication: 1 April 2007)
  • The prognosis for higher risk childhood B-cell non-Hodgkin lymphoma has improved over the past 20 years but the optimal intensity of treatment has yet to be determined. Children 21 years old orExpand
  • Hugh Grant Prentice, I. M. Hann, +10 authors Brenda E S Gibson
  • Medicine
  • British journal of haematology
  • 1997 (First Publication: 1 September 1997)
  • One hundred and thirty-four adults and 204 children were randomized in two prospective, parallel comparative multicentre trials to receive either conventional amphotericin B 1 mg/kg/d (c-AMB),Expand
  • Andrew D. J. Pearson, Charles Pinkerton, Ian J. Lewis, J. D. Imeson, Caroline Ellershaw, David Machin
  • Medicine
  • The Lancet. Oncology
  • 2008 (First Publication: 1 March 2008)
  • BACKGROUND The current standard treatment for patients with high-risk neuroblastoma includes initial induction chemotherapy with a 21-day interval between induction treatments. We aimed to assessExpand
  • Paul Leslie Ross Mitchell, Bruce Morland, +4 authors Charles Pinkerton
  • Medicine
  • Journal of clinical oncology : official journal…
  • 1997 (First Publication: 1 March 1997)
  • PURPOSE Infection in neutropenic patients is potentially life-threatening and carries important implications for hospital resource use. Prophylactic administration of cytokines may reduce theExpand
  • H A Cocker, Nicki Tiffin, Kathy Pritchard-Jones, Charles Pinkerton, Lloyd R. Kelland
  • Biology, Medicine
  • Clinical cancer research : an official journal of…
  • 2001 (First Publication: 1 October 2001)
  • We have established preclinical models for the development of drug resistance to vincristine (a major drug used in the treatment of pediatric rhabdomyosarcoma) using cell lines. The RD cell line hasExpand